重大事件
即時報告
8-K
2026-06-17
MIRA Pharmaceuticals提交8-K自願
AI 繁中摘要
MIRA Pharmaceuticals（MIRA）於2026年6月17日提交8-K表格，主要涉及Item 7.01（Regulation FD披露）及Item 9.01（財務報表與附件）📄。公司根據Regulation FD自願披露了特定信息，並隨附兩份附件：EX-99.1與EX-99.2（含圖形文件）。此類披露不視為正式提交至SEC，但可作為投資者了解公司最新動態的補充資料。目前無具體金額或季度業績數字，建議投資者仔細審閱附件內容，以評估潛在影響。🔍
展開英文正文
EDGAR Filing Documents for 0001493152-26-028992 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001493152-26-028992 Filing Date 2026-06-17 Accepted 2026-06-17 08:00:39 Documents 14 Period of Report 2026-06-17 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K form8-k.htm iXBRL 8-K 38067 2 EX-99.1 ex99-1.htm EX-99.1 22928 3 EX-99.2 ex99-2.htm EX-99.2 1538 4 GRAPHIC ex99-2_001.jpg GRAPHIC 830444 Complete submission text file 0001493152-26-028992.txt 1381111 Data Files Seq Description Document Type Size 5 XBRL SCHEMA FILE mira-20260617.xsd EX-101.SCH 3047 6 XBRL LABEL FILE mira-20260617_lab.xml EX-101.LAB 34239 7 XBRL PRESENTATION FILE mira-20260617_pre.xml EX-101.PRE 22380 17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3341 Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606 Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150 MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings) EIN.: 853354547 | State of Incorp.: FL Type: 8-K | Act: 34 | File No.: 001-41765 | Film No.: 261096632 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)